Biostar Pharmaceuticals Stock Shares Owned By Insiders
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Biostar Pharmaceuticals fundamentals help investors to digest information that contributes to Biostar Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Biostar Pink Sheet. The fundamental analysis module provides a way to measure Biostar Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biostar Pharmaceuticals pink sheet.
Biostar |
Biostar Pharmaceuticals Company Shares Owned By Insiders Analysis
Biostar Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 0.0% of Biostar Pharmaceuticals are shares owned by insiders. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Pharmaceuticals, Biotechnology & Life Sciences (which currently averages 0.0) industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.
Biostar Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biostar Pharmaceuticals' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biostar Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Biostar Pharmaceuticals by comparing valuation metrics of similar companies.Biostar Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Biostar Fundamentals
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 2.94 % | ||||
| Operating Margin | 8.76 % | ||||
| Current Valuation | 316.46 K | ||||
| Shares Outstanding | 2.64 M | ||||
| Number Of Shares Shorted | 170.44 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 317.79 K | ||||
| Gross Profit | 915.17 K | ||||
| EBITDA | (1.7 M) | ||||
| Net Income | (5.7 M) | ||||
| Cash And Equivalents | 364.97 K | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 0.19 X | ||||
| Book Value Per Share | 13.71 X | ||||
| Cash Flow From Operations | 4.91 M | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | 0.06 X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 200 | ||||
| Beta | -2923.36 | ||||
| Market Capitalization | 94 | ||||
| Total Asset | 42.5 M | ||||
| Retained Earnings | 3.16 M | ||||
| Working Capital | 9.07 M | ||||
| Current Asset | 16.17 M | ||||
| Current Liabilities | 7.1 M | ||||
| Net Asset | 42.5 M |
About Biostar Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biostar Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biostar Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biostar Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |